Vera Therapeutics (VERA) appointed Jason Carter as Chief Legal Officer, effective immediately. Carter has recently served as Global Head of Legal for Kite Pharma, where he oversaw legal and compliance activities supporting global product launches, R&D activities, manufacturing innovation and expansion, high-impact IP litigation, and M&A transactions. Prior to Kite, Carter served in a variety of senior legal roles, including at Daiichi Sankyo, Novartis, and Baxter. Earlier in his career, Carter practiced as an M&A and corporate securities attorney with Jenner & Block, and Vorys, Sater, Seymour & Pease.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Vera Therapeutics partners with University of Michigan on NEPTUNE match project
- Vera Therapeutics Advances in Autoimmune Treatment
- Vera Therapeutics reports Q3 EPS (85c), consensus (66c)
- Vera Therapeutics 7.14M share Secondary priced at $42.00
- Vera Therapeutics Advances Atacicept with Promising Trial Results